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ProliferationInduction of early pituitary progenitors is achieved through combined activities of signals from adjacent
embryonic tissues. Previous studies have identiﬁed a requirement for oral ectoderm derived Sonic Hedgehog
(Shh) in speciﬁcation and/or proliferation of early pituitary progenitors, however how different Gli genes
mediate Shh signaling to control pituitary progenitor development has not yet been determined. Here we
show that Gli2, which encodes a major Gli activator, is required for proliferation of speciﬁc groups of pituitary
progenitors but not for initial dorsoventral patterning. We further show that the action of Gli2 occurs prior to
the closure of Rathke' pouch. Lastly, we show that Shh/Gli2 signaling controls the diencephalic expression of
Bone morphogenetic protein 4 (Bmp4) and Fibroblast growth factor 8 (Fgf8), two genes that are known to play
critical roles in patterning and growth of Rathke's pouch. Our results therefore suggest both cell-autonomous
and non-cell-autonomous requirements for Gli2 in regulation of pituitary progenitor speciﬁcation,
proliferation and differentiation.e Western Reserve University
106,USA. Fax:+12163683432.
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The pituitary gland is a master endocrine organ that produces a
number of hormones regulating many essential physiological func-
tions in the body. It is comprised of the adenohypophysis (anterior
and intermediate lobes) and neurohypophysis (posterior lobe). The
anterior lobe contains ﬁve different hormone-producing cell types
that secrete adrenocorticotropic hormone (ACTH), growth hormone
(GH), prolactin (PRL), thyroid-stimulating hormone (TSH), luteiniz-
ing hormone (LH) and follicle-stimulating hormone (FSH) while the
posterior lobe contains nerve endings that secrete oxytocin and
vasopressin (Reviewed in Camper et al., 2002; Zhu et al., 2007). Both
hypopituitarism and hyperpituitarism have been identiﬁed in a
number of human congenital pituitary disorders (Dattani et al.,
1998; Pfafﬂe et al., 1992; Roessler et al., 2003; Thomas et al., 2001;Wu
et al., 1998).
Development of the pituitary gland requires extensive interactions
between different embryonic tissues. Between ~E8.5 and E9.0, a
portion of the oral ectoderm thickens and invaginates to form a
structure called Rathke's pouch (RP). Several lines of evidence suggest
that induction of RP requires signals derived from the diencephalon.First, mutation of T/ebp (Nkx2.1), which is expressed in the ventral
diencephalon but not in RP, causes apoptosis and degeneration of
nascent RP (Takuma et al., 1998). Second, mutation of Bmp4, which is
expressed in the ventral diencephalon, causes a loss of early RP (Takuma
et al., 1998; Winnier et al., 1995). Similar phenotypes were also
observed in embryos over-expressing Noggin, a BMP antagonist, in the
oral ectoderm (Treier et al., 1998). On the other hand, mutation of
Noggin results in expansion of pituitary tissues (Davis and Camper,
2007). Lastly, analysis of embryos mutant for Fgfr2, which encodes a
receptor for FGF1/3/7/10 and is expressed in the diencephalon, revealed
a requirement for FGF signaling in the diencephalon (De Moerlooze
et al., 2000). In both Fgfr2 and Fgf10mutants, increased apoptosis causes
severe defects in infundibulum and RP development (De Moerlooze
et al., 2000; Ohuchi et al., 2000). By ~E11, RP closes off from the oral
ectoderm and by ~E12, RP detaches from the oral ectoderm.
Interestingly, the critical period for pituitary progenitor speciﬁcation
appears to be between ~E10 and ~E12/13. Nascent RP isolated from
E10.5 mouse embryos will express early markers of pituitary pouch Isl1
but not Lhx3 (Lim1) when cultured in vitro. When combined with
ventral diencephalic tissues, nascent RP can be induced to express Lhx3
and other pituitary markers (Ericson et al., 1998). The action of
diencephalic tissues can be recapitulated by beads soaked with FGF8,
suggestingat least that FGF8 secreted fromthediencephalon is critical in
specifying different pituitary cell types. However, by E11.5, the pituitary
explants become refractory to FGF8 induction (Ericson et al., 1998). By
E12/13 (E13/15 in rat embryos), isolated RP can differentiate into
different pituitary cell types even when cultured alone, suggesting that
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from the underlying oral ectoderm (Nemeskery et al., 1976).
In addition to dorsal diencephalic signals, Shh is expressed in the
oral ectoderm immediately adjacent to RP (Treier et al., 1998). The
requirement of Shh signaling in pituitary development is supported
by the following experiments. Over-expression of Shh in the
developing RP using an αGSU promoter, which drives ectopic
expression of Shh in RP starting from ~E12.5, results in an expansion
of ventral pituitary cell markers TSH and LH and causes pituitary
hyperplasia (Treier et al., 2001). On the other hand, blocking Shh
signaling through expression of a Shh antagonist, Hedgehog-inter-
acting protein (Hhip), using the Pitx1 promoter causes pituitary
hypoplasia (Treier et al., 2001). However, interpretation of some of
these results is complicated by the fact that manipulations of secreted
signals can affect multiple tissues. In addition to the oral ectoderm,
Shh is also abundantly expressed in the ventral diencephalon,
immediately above the early RP. As a result, RP may be exposed to
Shh derived from both oral ectoderm and ventral diencephalon, and
the above experiments might have affected oral ectoderm and
diencephalon development in addition to development of RP.
Preliminary analysis of the pituitary phenotype resulting from a loss
of Gli2, which encodes the major Gli activator, provides some initial
insight into the requirement of Gli genes. Mutations in Gli2 result in a
variable loss of pituitary, demonstrating a requirement for Shh/Gli2
signaling in pituitary development (Park et al., 2000). However,
whether different cell types are generated in the anterior pituitary or
whether the development of posterior pituitary is affected has not yet
been determined. To address how Gli genes mediate Shh signaling to
control pituitary-speciﬁcation and proliferation, we analyzed pitui-
tary phenotypes of embryos mutated for individual Gli genes, which
are required for the transcription output of Shh signaling. We then
conditionally disrupted Gli genes in RP and found a critical role for Shh
signaling before RP detached from the oral ectoderm. Lastly, we found
Shh signaling is also required in the diencephalon to control pituitary
development through the regulation of two critical growth factors.
Material and methods
Mouse breeding
Mouse breedingwas carried out according to protocols approved by
CaseWesternReserve University (CWRU) Institutional Animal Care and
Use Committee. The Rosa26-lacZ Reporter (R) mouse (Soriano, 1999)
was used to monitor Cre-mediated recombination. To generate
FoxG1Cre;Gli conditional mutant embryos, FoxG1Cre;Gli2zfd/+ male
mice were bred to Gli2ﬂox/ﬂox;R/R or Gli2ﬂox/ﬂox;Gli3xt/+;R/R female mice.
To generate embryos with activated Hh signaling in RP, Pitx2Cre male
mice were bred to R26SmoM2 female mice. To generate Gli2 mosaic
embryos, Gli2lacZ/+ mice were bred with Gli2zfd/+; Rosa26 (R26)-EGFP/
R26-EGFP mice. The resulting morula stage embryos were co-cultured
withCD1 embryos. Embryos that had aggregated after overnight culture
were then transferred into pseudo-pregnant female for further
development. The genotyping of Cre, Gli2ﬂox, Gli2lacZ, Gli2zfd and Gli3xt
mice has been described (Bai et al., 2002; Bai and Joyner, 2001; Corrales
et al., 2004; Jeong et al., 2004; Maynard et al., 2002; Mo et al., 1997).
Histology, immunostaining and RNA in situ hybridization
Embryos were dissected in cold PBS and ﬁxed in 4% paraformalde-
hyde (PFA) for 1–3 h at 4 °C, washed with PBS, sunk in 30% sucrose and
embedded inOCT (Tissue-Tek). Sagittal tissue sectionswere collected at
12 μm on a Leica Cryostat. 3–6 embryos were analyzed for each
embryonic stage. Methods of X-gal staining, antibody staining and RNA
in situ hybridization have been described (Bai et al., 2002; Bai and
Joyner, 2001). The following antibodies were used: Pax6 (1:500,
Covance), Isl1 (1:100, Abcam), Lhx3 (1:100, Developmental StudiesHybridomaBank), BrdU(1:20, Becton-Dickinson), Ki67 (1:500, Abcam),
phospho-Histone H3 (1:100, Upstate), cleaved Caspase-3 (1:200, Cell
Signaling), ACTH (1:1000), GH (1:1000), LH (1:500), PRL (1:2500) and
TSH (1:500, all from National Hormone & Peptide Program) and
β-galactosidase (1:500, Biogenesis). Hoechst 33258 (Molecular Probes)
was used to visualize nuclear staining. All sections were examined with
a Leica DMLB epi-ﬂuorescencemicroscope ﬁttedwith a SPOT camera in
the CWRU Genetics Imaging Facility (supported by NIH-NCRR,
RR-021228).
BrdU labeling, cell cycle, cell death analysis and quantiﬁcation
Pregnant mice were injected intraperitoneally with BrdU (Sigma)
at 100 μg/g body weight 1 h prior to dissection. The percentage of
BrdU+, Ki67+, pHH3+, Caspase3+ cells was calculated by dividing
the number of the positive cells by the total number of nuclei
(Hoechst) inside RP or other speciﬁed region. To calculate the fraction
of S-phase cells within cell cycle, we divided the number of BrdU+
cells by the total number of Ki67+ cells and converted the number to
a percentage. For each time point, we used 2 mid-sagittal sections
from each embryo and 4–6 embryos from at least two different litters
for analysis. As the number of Caspase3+ cells is low in both WT and
Gli2 mutants, we counted 3–4 sections from each embryo (total 1–5
Caspase3+ cells per embryo, with n=3 for Gli2mutants and n=6 for
WT). The number in charts was displayed as mean±S.E.M. Student's
t-test was used to calculate the P value and to determine whether the
results were signiﬁcantly different from each other (** indicates
Pb0.01; * indicates Pb0.05).
Quantiﬁcation of pituitary cell types at E17.5. To ensure consistent
sampling of cell types among different embryos, we performed
immunostaining analysis for each marker on two mid-sagittal
sections from each embryo. A total of 6 WT embryos, 6 Gli2−/−
embryos and 4 FoxG1Cre;Gli2−/− embryos from at least three litters
were used in the analysis.
We used the following method to normalize the contribution of
EGFP-labeled cells to RP of mosaic embryos. We ﬁrst selected an area in
the dorsal mid/hindbrain region, which does not have active Shh/Gli
signaling, and calculated the percentage of EGFP+ cells over the total
number of cells. This number was used as a baseline for the level of
mosaicism in that embryo.We then calculated the percentage of EGFP+
cells within RP or in different regions of RP, and normalized the
percentage against the baseline in that embryo. Results from three
embryos were then used to determine whether there was a signiﬁcant
difference between the contribution of WT and Gli2mutant cells.
Results
Loss of Gli2 leads to a selective loss of speciﬁc pituitary cell types
Previous studies reported a variable loss of the pituitary (3/6) in
Gli2 mutants when examined at E12.5 (Park et al., 2000). To
determine how Gli2 mediates Shh signaling to inﬂuence pituitary
development, we examined patterning of the pituitary gland and the
production of different pituitary cell types in wild type (WT) and
mutant embryos.
We ﬁrst examined the expression of two markers that are normally
expressed throughout the E12.5 pituitary pouch, Lhx3 and Prop1. Lhx3
encodes a LIM-homeodomain transcription factor that is required for
speciﬁcation of pituitary cell lineages (Sheng et al., 1996) and Prop1
encodes a paired-like homeodomain transcription factor required for
initial determination of the Pit1 (Poulf1)-expressing lineage of the
pituitary (Sornson et al., 1996). In Gli2 mutants, both Lhx3 and Prop1
were found throughout the pituitary gland, suggesting that early
pituitary cells were speciﬁed normally (Figs. 1A–D).We then examined
the expression of markers for different regions of the pituitary pouch.
Gata2 encodes for a ventrally restricted transcription factor that is
Fig. 1. Gli2mutant pituitaries havenormal patterning but showdefects in proliferation. (A–F) RNA in situhybridization ofwild type (WT) andGli2mutants using probes of Lhx3, Prop1 and
Gata2. (G–J) Immunostaining of Pax6 and Isl1. (K–P) Analysis of proliferation and cell death by immunostaining of Ki67, BrdU, pHH3 and Caspase3 in Rathke's pouch. Note: The strong
background staining in (L) is likely caused by leaky vasculature and elevated levels of mouse endogenous IgG in Gli2mutants. (Q) Quantiﬁcation of BrdU incorporation, the expression of
Ki67 and Caspase3. The percentage of BrdU+, Ki67+, pHH3+, Caspase3+ cells was calculated by dividing the number of the positive cells by the total number of nuclei (Hoechst). All
embryos (n=6) were at E12.5. * indicates Pb0.05, ** indicates Pb0.01. Scale bars: 100 μm.
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most of which have just exited cell cycle at E12.5 (Dasen et al., 1999;
Treier et al., 1998) (Fig. 1E). In Gli2mutants, Gata2+cells were found in
the anterior tip of the pouch, as was the case in WT embryos (Fig. 1F).
We also examined the expression of two other pituitary markers, Pax6
and Isl1. Pax6 is normally expressed in a dorsal-to-ventral gradient and
Isl1 is restricted to the pituitary tip at E12.5 (Figs. 1G,I). The expression
pattern of Pax6 and Isl1 in Gli2mutants is similar to the pattern seen in
WT embryos (Figs.1H,J). This demonstrates that loss of Gli2 does not
affect the overall patterning of the pituitary.
Although patterning of the Gli2 mutant pituitary is largely normal,
mostGli2mutant pituitarieswere found tobe smaller thanWTpituitaries
(Fig. 1), suggestingdefects in cell proliferation and/or excessive cell death
in mutant pituitary tissues. To distinguish between these two possibil-
ities, we examined expression of Ki67, a marker for proliferating cells,
BrdU incorporation, a marker for cells in S-phase, and phospho-Histone
H3 (pHH3), a marker for cells in M-phase. At E12.5, we detected
reductions in the percentage of cells expression Ki67 in Gli2 mutantpituitaries (Figs. 1K,L,Q, P=0.009), BrdU+cells (Figs. 1K,L,Q, P=0.0006)
and cells in M-phase based on pHH3 levels (Figs. 1M,N, P=0.0123). To
test if excessive cell death contributed, we examined the expression of
cleaved-Caspase3 and found no signiﬁcant difference between mutant
andWTpouches (Figs. 1O,P). Together, thesedata suggest that loss ofGli2
affects proliferation of pituitary progenitor cells at E12.5.
To determinewhether loss of Gli2 affects the production of different
pituitary cell types, we analyzed the expression of cell-type speciﬁc
markers at E17.5, a stage when all mature cell types are normally
present (Figs. 2A–J). Five hormone-secreting cell types we examined
include corticotropes (C), which secrete ACTH; thyrotropes (T), which
secrete TSH; gonadotropes (G), which secrete LH; somatotropes (S),
which secreteGH; and lactotropes (L),which secretePRL.We found that
all ﬁve markers were detected in Gli2 mutant pituitaries (Figs. 2A–J).
However, when the number of different cell types was counted in Gli2
mutants, we found a reduction in the number of C, S and L cells (Fig. 2K),
suggesting a requirement for Gli2 for normal generation of these three
cell types.
Fig. 2. Thenumberof corticotropes, somatotropes and lactotropes is reduced inGli2mutants
at E17.5. (A–J) Immunostaining of different pituitary cell type markers ACTH, GH, LH, PRL
and TSH in WT and Gli2 mutant pituitaries. Outlined areas in WT represent anterior and
posterior pituitaries. In Gli2mutants, only anterior pituitary is present. (K) Quantiﬁcation of
each pituitary cell type in WT and Gli2 mutants (* indicates Pb0.05, ** indicates Pb0.01,
n=6 embryos). Two mid-sagittal sections from each embryo were used to quantify the
number of different cell type.
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expression of Gli2
Several possibilities could account for the proliferation defects in
Gli2mutant pituitaries. First, Gli2 is required cell-autonomously in RPto respond to Shh signal derived from the oral ectoderm, as suggested
by previous studies (Treier et al., 1998). Second, Gli2 could be required
for cells in RP to respond to diencephalic derived Shh. Third, Gli2may
be required in the diencephalon for the expression of other growth
signals, as diencephalic defects were found in Gli2 mutants in our
previous study (Park et al., 2000). To distinguish these possibilities,
we generated Gli2 mosaic embryos and analyzed mutant cells in an
otherwise WT background.
Two different Gli2 alleles, Gli2zfd and Gli2lacZki (Bai and Joyner,
2001; Mo et al., 1997), were used to generate Gli2 mutant embryos.
EGFP+ embryos were derived by crossing Gli2lacZki/+ and Gli2zfd/+;
EGFP/EGFP mice. The EGFP-labeled embryos were then aggregated
with morula stage, unlabeled CD1 embryos in vitro. After overnight
incubation, those embryos that had successfully aggregated were
transferred into pseudo-pregnant females and allowed to develop.
Embryos were then dissected and genotyped with primers for the two
Gli2 alleles. Those that contained Gli2zfd, Gli2laczki and WT Gli2 alleles
were mosaic embryos containing WT and Gli2 mutant cells while
those that contained only Gli2lacZki and WT Gli2 alleles were used as
controls. Both control and mosaic embryos appeared to have
morphologically normal RP (Figs. 3A–F). To determine whether Gli2
mutant cells can compete withWT cells and adopt a pituitary cell fate,
we stained mosaic pituitary with Lhx3 antibody (Figs. 3A,D). We
found that all EGFP+ Gli2 mutant cells expressed Lhx3 in mosaic
pituitary examined (Figs. 3B,E, n=3), suggesting that Gli2 mutant
cells can contribute to pituitary and adopt pituitary cell fate in mosaic
embryos (Figs. 3C,C′,F,F′). However, there were fewer EGFP positive
cells in mosaic Gli2 pouches (Figs. 3E,K,N) than in controls (Figs. 3B,
H). To determine whether GFP+ mutant cells are less likely to be
integrated into mosaic pituitaries, we divided RP into two regions,
anterior wall (A) and posterior wall (P), along the pouch lumen
(Fig. 3M). When we calculated the percentage of GFP+ cells in each
division and normalized this number to the level of mosaicism in each
embryo (see Materials and methods), we found mutant cells
contributed signiﬁcantly less to the anterior wall of the pituitary
(Fig. 3N, PA=0.002). Interestingly, mutant cells contributed less to
the posterior wall as well, although the reduction was not as dramatic
(Fig. 3N, PP=0.031). Lastly, mutant cells were also underrepresented
in the infundibulum (Fig. 3N, PI=0.011), suggesting a requirement of
Shh/Gli2 signaling in the development of posterior pituitary.
One potential reason why there are fewer mutant cells in the
anterior wall of the pouch is that mutant cells do not proliferate as well
as WT cells. To determine whether this was the case, we counted the
number of EGFP+ BrdU+ mutant cells and the total number of
unlabeled, BrdU+ S-phase cells (Figs. 3G–L), and calculated the
percentage of mutant cells over the total number of S-phase cells in
each region (Fig. 3O). Indeed, we found EGFP+ cells were proliferating
less in the anterior wall of the pouch (Fig. 3O). There were also fewer
proliferating EGFP+ cells in the posterior wall, although the reduction
was not as drastic as in the anterior wall of the pouch, suggesting that
the reason therewere fewer Gli2mutant cells inside RP is that there is a
cell-autonomous requirement of Gli2 for proliferation.
Removal ofGli2 functionbefore the closure ofRP causes proliferation defects
in some pituitary progenitors
Previous studies have shown that pituitary development is controlled
by Shh expressed from the oral ectoderm (Treier et al., 1998, 2001). To
determine the critical period of Shh/Gli signaling for pituitary prolifer-
ation, we conditionally removed Gli2 function in the pituitary by using a
conditional Gli2 allele and two Cre lines, FoxG1Cre (Hebert and
McConnell, 2000) and Pitx2Cre (Liu et al., 2003).
FoxG1 (Forkhead box G1) is initially expressed in the anterior neural
ridge and in the early telencephalon (Shimamura and Rubenstein,
1997). To determine whether FoxG1Cre can be used to remove Gli2
function before RP closes, we used FoxG1Cre to recombine a Rosa26-lacZ
Fig. 3. Inmosaics, Gli2mutant cells do not contribute aswell in the anterior edge of the pituitary due to reduced proliferation there. (A–F) Immunostaining of Lhx3 inWT and Gli2mosaic
embryos. (C′,F′,I′,L′) are higher magniﬁcation images of corresponding boxes indicated. Note: EGFP is expressed in cytoplasm while Lhx3 and BrdU are present in nuclei. (G–L)
Immunostaining of BrdU and EGFP in WT and Gli2mosaic embryos. EGFP+ cells in WT embryos (A–C, G–I) were Gli2+/+ while EGFP+ cells in Gli2mosaic (D–F, J–L) were Gli2zfd/lacki.
(M) Schematic representationof the subdivisions of thepituitary. R, rostral; C, caudal. (N)Distributionof EGFP+cells inanteriorwall (A) andposteriorwall (P) of theanterior pituitary, and
in infundibulum. (O) Distribution of BrdU+;EGFP+/BrdU+ cells in different regions of the anterior pituitary (PAb0.01; PP=0.105). See Material and methods for normalization of the
number of EGFP+ cells in each embryo. The anterior pituitary was outlined by dotted lines. White arrowheads indicate cells double-labeled with both green and red. Scale bars: 100 μm.
* represents Pb0.05, ** represents Pb0.01.
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from the Rosa26-lacZ reporter. We found that at E9.5, all cells
encompassing the invaginating RP were positive for β-galactosidase
(Fig. 4A). The staining of β-galactosidase within all RP cells was
conﬁrmed at E10.5 and E12.5 (Figs. 4B,C), suggesting that FoxG1Cre can
be used to disrupt Gli2 function before the closure of RP. As FoxG1 is not
expressed in the diencephalon, the manipulation should not affect thenormal role of thediencephalon in regulating thegrowth andpatterning
of the pituitary.
At E12.5, the pituitaries of conditional Gli2 mutants (FoxG1Cre;
Gli2ﬂox/zfd) appearedmorphologically normal. Analysis of early pituitary
markers, Lhx3, Prop1, Gata2, Pax6 and Isl1, also revealed a pattern of
expression resembling that of theWT embryos (Fig. S1A–K), consistent
with our results that Gli2 does not control pituitary patterning (Fig. 1).
Fig. 4. Early loss of Gli2 function results in proliferation defects in progenitors in the anterior-ventral pituitary. (A–C) FoxG1Cre activity can be detected before the closure of RP, as
revealed by X-gal staining at E9.5 (A) and E10.5 (B), and by immunostaining at E12.5 (D–I). Analysis of proliferation and cell death in E12.5 WT and FoxG1Cre;Gli2 conditional
mutants. (J) Schematics of subdivisions of the pituitary. (K,L) Quantiﬁcation of BrdU incorporation and the ratio of BrdU/Ki67 in different regions of the pituitary. Scale bars: 100 μm.
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signaling to control progenitor proliferation before the closure of RP,
then we would expect proliferation defects in the FoxG1Cre; Gli2ﬂox/zfd
conditional mutants. To this end, we examined the proliferation of
conditional mutant cells at E12.5 by analyzing BrdU incorporation and
expressionofKi67 andpHH3. ComparedwithWTembryos,we foundno
signiﬁcant differences in the percentage of cells incorporating of BrdU,
or cells expressing Ki67 and pHH3 in conditional Gli2mutants (Figs. 4D,
G). Furthermore, removal ofGli2didnot change thepatternof cell death,as there was no signiﬁcant change in the number of cells expressing
Caspase3 (Figs. 4F,I). To determine whether there are regional
differences in cell proliferation, we divided the pouch into four regions:
anterior (dorsal and ventral, Ad and Av respectively), rostral tip (rT) and
posterior (P) (Fig. 4J). At this stage, most of the rT cells had already
exited the cell cycle while the rest of the cells in RP were still
proliferating. Interestingly we found a decrease in the percentage of
BrdU incorporation in the Av region of the FoxG1Cre;Gli2 mutants
(Fig. 4K). The reduction in BrdU incorporation appeared to reﬂect a
205Y. Wang et al. / Developmental Biology 348 (2010) 199–209reduction in proliferation, rather than changes in cell cycle length, as the
number of proliferating cells (Ki67+) was also decreased and the ratio
of BrdU/Ki67 remained largely unchanged (Fig. 4L).
If proliferation of progenitors in the Av region was affected, then we
would expect to see a reduction in the number of mature pituitary cells
generated from this region.We therefore quantiﬁed the number of each
mature pituitary cell type in FoxG1Cre;Gli2mutants at E17.5 (Figs. 5A–J).
Consistent with this expectation, we found a smaller number of
corticotropes (C) and lactotropes (L) (Fig. 5K), suggesting a requirement
of Gli2 in the proliferation and differentiation of their precursors.
The reduction in the number of pituitary cells could impede
normal growth during the early postnatal period. To test whether this
is the case, we monitored the growth of FoxG1Cre;Gli2 mutant pups.
Compared with WT pups, mutant pups had a lower body weight
(Fig. 5L), and even though mutant pups were born alive, most died
within 30 days after birth. The growth defects in FoxG1Cre;Gli2
mutants likely reﬂect disruption of pituitary function, although the
possibility that it might also result from loss of Gli2 function in
endodermal tissues was not examined.
We also used Pitx2Cre, which is active in RP (Liu et al., 2003) slightly
later than FoxG1Cre to disrupt Gli2 function. Pitx2Cre-mediated
recombination of Rosa26-lacZ can be detected in a few cells at E9.5
andmore cells at E10.5 and E12.5 (Figs. 6A–C). However, when Pitx2Cre
was used to remove Gli2 function, we found no obvious defects in
patterning or proliferation of mutant pituitaries at E12.5 (data not
shown), suggesting that Gli2 is required before Pitx2Cre is active in RP.
Overlapping roles of Gli genes in pituitary development
Previous studies have shown that the three Gli genes share
overlapping and redundant functions (Bai et al., 2004). To address
whether Gli2 is the primarily Gli transcription factor to mediate ShhFig. 5. Early loss of Gli2 function results in the reduction of corticotropes and lactotropes at E1
different pituitary cell types inWT and FoxG1Cre;Gli2mutants (* denotes Pb0.05, ** denotes P
birth. Seven pups from four litters were tracked for each genotype. The number on each dosignaling during pituitary development, we analyzed the pituitary
phenotypes of Gli1 and Gli3 mutants at E12.5. Both mutants had
normal pituitary patterning and proliferation at E12.5 (data not
shown), consistent with the notion that Gli2 is the primary Gli
transcription factor in the pituitary. We next examined pituitary
development in Gli2/Gli3 double mutants, which do not express Gli1
and therefore lose all Gli function (Bai et al., 2004), and found no
pituitary in all double mutants examined (n=4). One potential
reason for the complete loss of pituitary in Gli2/Gli3 double mutants is
that Gli mediated Shh signaling is required in the diencephalon for the
initial formation of RP. To address this issue, we generated conditional
mutant embryos that lost all Gli function speciﬁcally in the pituitary
using FoxG1Cre (FoxG1Cre; Gli2ﬂox/zfd;Gli3xt/xt). At E12.5, the pituitary
gland in these conditional mutant embryos was smaller. However,
when pituitary speciﬁc cell markers were used to examine the initial
patterning, we found that Lhx3 is expressed normally throughout the
pituitary gland (data not shown). In addition, Isl1 showed typical
staining in the rostral tip and Pax6 appeared to express in a dorsal-to-
ventral pattern, similar toWT embryos at this stage (Fig. S1K,L). These
results conﬁrm that early pituitary patterning is not affected by loss of
Gli function, and that excessive production of Gli repressor in pitx1-
Hhip transgenic embryos, as in Shh mutants, may be responsible for
the severe pituitary phenotypes.
Activation of Hh signaling in RP increases pituitary proliferation without
affecting patterning
If disruption of Gli function affects pituitary cell proliferation, then
we expect that activation of Shh signaling increase pituitary
proliferation. To test this, we activated Hedgehog (Hh) signaling
using Pitx2Cre and a conditional allele encoding an active form of Smo
inserted in the Rosa26 locus (R26SmoM2) (Jeong et al., 2004). At E12.5,7.5. (A–J) Immunostaining of different pituitary cell type markers. (K) Quantiﬁcation of
b0.01, n=6 embryos). (L) FoxG1Cre;Gli2mutants did not grow aswell asWT pups after
t indicates surviving pups at that time. Scale bars: 100 μm.
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Fig. 7. Gli2 is required for the expression of Bmp4 and Fgf8 in the ventral diencephalon. (A–L) RNA in situ hybridization of Shh, Bmp4 and Fgf8 in E9.5 embryos (A,B,E,F,I,J) and embryo
sections (C,D,G,H,K,L). Red arrows indicate diencephalic expression. Scale bars: 100 μm.
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pouches, as Lhx3, Prop1, Gata2 and Isl1 were expressed normally
(Figs. 6D–K). The expression pattern of these markers remained
unchanged even when examined at E14.5 (Figs. 6O–V), suggesting
that activation of Hh signaling using Pitx2Cre does not alter the
general patterning of the pituitary.
We next examined markers for cell proliferation in mutant pituitary
pouches. Although therewere no signiﬁcant differences in the number of
Ki67+ and pHH3+ cells in the whole pituitary pouch (data not shown),
the number of proliferating cells (BrdU+ and BrdU/Ki67) was
signiﬁcantly increased in the Ad region of the pouch (Figs. 6L,M,N). The
observation that cells in the dorsal anterior region over proliferate in
response to Shh signaling suggests that these cells normally do not
receive saturating amounts of Shh. The phenotype became more
prominent at E14.5, as Pitx2Cre;SmoM2 mutant pituitaries were much
bigger in size thanWTcontrols (Figs. 6O–V). Together, thesedata support
our observation that the primary role of Shh/Gli2 signaling is to control
the proliferation, rather than patterning, of pituitary progenitors.
Patterning of pituitary requires diencephalic function of Gli2
In addition to the partial loss of anterior pituitary as reported
previously (Park et al., 2000), we found that all Gli2 mutants had no
posterior pituitary (n=43). The complete loss of the posterior
pituitary suggests a requirement of Gli2 in ventral diencephalon. As
diencephalon-derived signals such as BMP4 and FGF8 are required for
induction and proliferation of the anterior pituitary (Ericson et al.,
1998; Takuma et al., 1998; Treier et al., 1998), we were curious
whether the expression of these two signals was perturbed in Gli2
mutants.We therefore examined the expression of Shh, Bmp4 and Fgf8
in Gli2 mutants using in situ hybridization on E9.5 embryos and onFig. 6. Activation of Hh signaling using Pitx2Cre resulted in increased proliferation in the anterio
(D–K) Analysis of patterningmarkers in E12.5WT embryos and in embryos with activatedHh s
(G, K). (L,M) Immunostaining of BrdU incorporation and the expression of Ki67. (N) Quantiﬁcat
Activation of Hh signaling did not affect pituitary patterning, as revealed by RNA in situ hybridembryo sections (Fig. 7). We found a normal expression of Shh in the
ventral diencephalon of Gli2 mutants (Figs. 7A,B). However, while
Bmp4was detected strongly in the medial ventral diencephalon inWT
embryos (Fig. 7E), no Bmp4 expression was detected in the ventral
diencephalon of Gli2 mutants (Fig. 7F, n=3 embryos). Similarly,
while Fgf8 is strongly expressed in the diencephalon of WT embryos
(Fig. 7I), the expression in Gli2 mutants was greatly reduced (Fig. 7J,
n=3 embryos). Similar results were obtained when in situ hybrid-
ization was performed on E9.5 embryo sections (Figs. 7C,D,G,H,K,L,
n=7 embryos). Together, these results suggest that Gli2 is required
for diencephalic expression of Bmp4 and Fgf8 and that the loss of
expression of these two genes in diencephalon may be responsible for
the variable pituitary phenotypes in Gli2 mutants.
Discussion
Shh signaling is primarily required for proliferation, rather than speciﬁcation,
of early pituitary progenitors
Shh signaling has been shown to be involved in controlling cell fate
speciﬁcation and proliferation in different tissues. In the spinal cord,
Shh can induce different types of spinal cord neurons based on the
concentration of Shh or the length of action (Dessaud et al., 2008). In
the cerebellum, however, themajor function of Shh appears to control
proliferation of granular precursors (Kenney and Rowitch, 2000).
Analysis of Gli mutants and gain-of-function embryos provided
further support that Gli transcription factors, in particular Gli2,
mediate different functions of the Shh signaling in different tissues.
For example, Gli2 mutants do not generate ﬂoor plate cells and have
only residual V3 interneurons in the spinal cord (Ding et al., 1998;
Matise et al., 1998). Similarly, Gli2 mutants have defects in ther-dorsal pituitary. (A–C) X-gal staining revealed the activity of Pitx2Cre fromE9.5 to E12.5.
ignaling (Pitx2Cre;SmoM2) using RNA in situ hybridization (D–F,H–J) and immunostaining
ion of BrdU incorporation and Ki67 expression. (* indicates Pb0.05, n=6 embryos). (O–V)
ization of markers at E14.5. Scale bars: 100 μm.
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other hand, Gli2 mutants show reduced proliferation of granular
progenitors but no loss of cell types in the cerebellum (Corrales et al.,
2004).
Because Shh mutants have severe patterning defects during early
embryonic development, the role of Shh signaling in pituitary
development has previously only been examined in gain- or loss-of-
function transgenic embryos (Treier et al., 2001). Blocking Shh
signaling by expressing Shh antagonist Hhip in the oral ectoderm
caused loss of anterior pituitary markers Gata2 and brn4 (Pou3f4), and
a smaller pituitary. On the other hand, ectopic expression of Shh in the
anterior pituitary resulted in the expansion of anterior marker Gata2,
increased production of pituitary cells and a bigger pituitary. In both
situations, changes in the expression of anterior markers were
accompanied by a corresponding change in cell proliferation. Our
current study provides several lines of evidence that Shh/Gli signaling
functions primarily to promote pituitary cell proliferation. First, the
patterning of Gli2 mutant pituitaries is largely normal but the
pituitaries have a clear proliferation defect. Second, Gli2 mutant
cells are less likely to contribute to the pituitary, in particular to
anterior pituitary, because these mutant cells do not proliferate as
well as WT cells in mosaic embryos. Lastly, patterning of early
pituitary is normal in conditional Gli2 mutants when Gli2 function is
disrupted by using FoxG1Cre or Pitx2Cre. Even when both Gli2 and Gli3
are disrupted in the pituitary, cells in RP still express appropriate
pituitary markers at E12.5.
Our analysis also revealed a critical window of Shh/Gli signaling in
controlling proliferation and differentiation of pituitary progenitors.
Removal of Gli2 using FoxG1Cre affects proliferation and differentiation
of several pituitary progenitors. These effects are direct results of loss of
Gli2 function in RP, as diencephalic expression of Bmp4 and Fgf8 is not
altered in these embryos (Supplementary Fig. S2). Additional removal of
all Gli function in the pituitary have a more drastic effect, as FoxG1Cre;
Gli2;Gli3 mutant pituitary glands are much smaller than FoxG1Cre;Gli2
pituitary glands. However, removal of Gli2 function using Pitx2Cre,
which becomes active slightly later that FoxG1Cre, does not appear to
have obvious effect on patterning or proliferation of the pituitary
progenitors. Nevertheless, ectopic activation of Shh signaling using
Pitx2Cre causesmassive over-proliferation of all pituitary progenitors of
the pituitary, suggesting that although Shh/Gli signaling is not required
at this stage, pituitary progenitors are still responsive to ectopic Shh
signaling. It further suggests that Shh signalingmust be tightly regulated
even at this later phase.
Although Hedgehog signaling is largely conserved across species,
clear differences exist as to how Hh/Gli signaling regulates pituitary
development in mouse and ﬁsh. In mouse, Gli2 functions as the major
activator and is required for pituitary development (Park et al., 2000),
while Gli1 and Gli3 are dispensable, although Gli1 is redundant in
function with Gli2. Furthermore, conditional removal of Gli2 or all Gli
function in pituitary reveals that Hh/Gli signaling controls proliferation,
rather than patterning, or early pituitary progenitors. Our analysis also
reveals that Hh/Gli signaling controls diencephalic expression of Bmp4
and Fgf8, which have been shown to control early pituitary patterning
and proliferation. On the other hand, zebraﬁsh dtr/gli1 is required for
normal development asdtr/gli1nullmutants have a pituitary phenotype
including a reduced expression of pituitarymarkers nk2.2 and Lim3, and
reduction in the number of somatotropes, lactotropes and anterior
corticotropes (Devine et al., 2009; Karlstrom et al., 2003). Blocking the
function of yot/gli2 results inminor pituitary phenotypes as the number
of corticotropes is reduced. However, blocking the function of both dtr/
gli1 and yot/gli2ab function results in a signiﬁcant reduction in almost all
anterior pituitary cell types (Devine et al., 2009), a phenotype that is
more severe than any single or compound mouse Gli mutants. It is
possible that the differences observed are species speciﬁc, as the
morphogenetic process of pituitary formation in zebraﬁsh is distinct
from that of the mouse or chick in at least two aspects. First, thezebraﬁsh pituitary primordium is formed as a solid structure at the
anterior edge of the head, which thenmoves caudally into the head in a
process that is different from that in chick or mouse. Second, the
formation of zebraﬁsh pituitary gland does not involve a structure
equivalent to Rathke's pouch and the invagination of oral/placodal
ectoderm (Glasgow et al., 1997; Herzog et al., 2003). In addition, there
are differences in the transcriptional regulation of Gli genes in mouse
and ﬁsh, asmouse Gli2 is not regulated by Hh signaling (Bai et al., 2002)
while the zebraﬁsh dtr/gli1 appears to be regulated by Hh signaling
(Devine et al., 2009). Alternatively, themore severe pituitary phenotype
in zebraﬁsh could also result from knockdown of gene function in both
pituitary and diencephalon.
Shh/Gli2 mediated diencephalic signal is required for pituitary
development
Our analysis of pituitary-speciﬁc Gli mutants revealed that
blocking of Shh signaling within pituitary progenitors reduces
proliferation and differentiation of pituitary progenitors but does
not signiﬁcantly affect patterning of the pituitary gland. But if that is
the case, why would half of the Gli2 mutants lack a pituitary? The
answer may be in the ventral diencephalon. Starting from E8.0, Shh is
strongly expressed in the ventral diencephalon, immediately above
the forming RP. Our previous analysis identiﬁed loss of ventral
diencephalic tissues and reduced expression of Nkx2.1 in some Gli2
mutants. As ventral diencephalon is an important tissue in the
induction of RP, we examined the expression of diencephalic marker
genes between E8.5 and E9.5. We found that Gli2 mutants had
reduced expression of Bmp4 and Fgf8, which are growth factors shown
to be critical for the development of a deﬁnitive pouch (Takuma et al.,
1998; Treier et al., 1998). Our study therefore identiﬁed two
requirements for Shh/Gli signaling that are critical for pituitary
progenitor development: one within RP to promote proliferation of
pituitary progenitors and a second role to control expression of Bmp4/
Fgf8 in the ventral diencephalon to control early patterning of RP.
Future work will be needed to determine whether the Gli2
transcription factor can bind directly to Bmp4/Fgf8 regulatory
elements to control their expression in the ventral diencephalon.
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